KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Charles River Laboratories International (CRL) Net Margin (2016 - 2025)

Charles River Laboratories International has reported Net Margin over the past 16 years, most recently at 27.82% for Q4 2025.

  • For Q4 2025, Net Margin fell 630.0% year-over-year to 27.82%; the TTM value through Dec 2025 reached 3.59%, down 385.0%, while the annual FY2025 figure was 3.59%, 385.0% down from the prior year.
  • Net Margin for Q4 2025 was 27.82% at Charles River Laboratories International, down from 5.42% in the prior quarter.
  • Over five years, Net Margin peaked at 18.46% in Q4 2023 and troughed at 27.82% in Q4 2025.
  • A 5-year average of 6.29% and a median of 8.96% in 2023 define the central range for Net Margin.
  • Biggest five-year swings in Net Margin: surged 267bps in 2022 and later plummeted -3997bps in 2024.
  • Year by year, Net Margin stood at 15.45% in 2021, then rose by 11bps to 17.19% in 2022, then increased by 7bps to 18.46% in 2023, then crashed by -217bps to 21.52% in 2024, then dropped by -29bps to 27.82% in 2025.
  • Business Quant data shows Net Margin for CRL at 27.82% in Q4 2025, 5.42% in Q3 2025, and 5.07% in Q2 2025.